Gilead Sciences

gilead-acquires-arcellx-for-7-8-billion-to-enhance-car-t-therapy

Gilead Acquires Arcellx for $7.8 Billion to Enhance CAR-T Therapy

Editorial 23 February, 2026

Gilead Sciences has announced its acquisition of Arcellx, a partner in its cell therapy...

trump-administration-secures-drug-price-agreements-with-nine-firms

Trump Administration Secures Drug-Price Agreements with Nine Firms

Editorial 20 December, 2025

The Trump administration has announced agreements with nine additional pharmaceutical companies aimed at aligning...